Abstract:Abstract Aims/hypothesis Protein kinase CK2 acts as a negative regulator of insulin expression in pancreatic beta cells. This action is mainly mediated by phosphorylation of the transcription factor pancreatic and duodenal homeobox protein 1 (PDX1). In pancreatic alpha cells, PDX1 acts in a reciprocal fashion on glucagon (GCG) expression. Therefore, we hypothesised that CK2 might positively regulate GCG expression in pancreatic alpha cells. Methods We suppressed CK2 kinase activity in αTC1 cells by two pharmacological inhibitors and by the CRISPR/Cas9 technique. Subsequently, we analysed GCG expression and secretion by real-time quantitative RT-PCR, western blot, luciferase assay, ELISA and DNA pull-down assays. We additionally studied paracrine effects on GCG secretion in pseudoislets, isolated murine islets and human islets. In vivo, we examined the effect of CK2 inhibition on blood glucose levels by systemic and alpha cell-specific CK2 inhibition. Results We found that CK2 downregulation reduces GCG secretion in the murine alpha cell line αTC1 (e.g. from 1094±124 ng/l to 459±110 ng/l) by the use of the CK2-inhibitor SGC-CK2-1. This was due to a marked decrease in Gcg gene expression through alteration of the binding of paired box protein 6 (PAX6) and transcription factor MafB to the Gcg promoter. The analysis of the underlying mechanisms revealed that both transcription factors are displaced by PDX1. Ex vivo experiments in isolated murine islets and pseudoislets further demonstrated that CK2-mediated reduction in GCG secretion was only slightly affected by the higher insulin secretion after CK2 inhibition. The kidney capsule transplantation model showed the significance of CK2 for GCG expression and secretion in vivo. Finally, CK2 downregulation also reduced the GCG secretion in islets isolated from humans. Conclusions/interpretation These novel findings not only indicate an important function of protein kinase CK2 for proper GCG expression but also demonstrate that CK2 may be a promising target for the development of novel glucose-lowering drugs. Graphical Abstract

Pancreatic Glucokinase is Activated by Insulin-Like Growth Factor-I

Regulation of Glucokinase by Intracellular Calcium Levels in Pancreatic β Cells

Forkhead Box O1/Pancreatic and Duodenal Homeobox 1 Intracellular Translocation is Regulated by C-Jun N-Terminal Kinase and Involved in Prostaglandin E-2-Induced Pancreatic Beta-Cell Dysfunction

GSK3 Protein Positively Regulates Type I Insulin-like Growth Factor Receptor Through Forkhead Transcription Factors FOXO1/3/4

Glucokinase and Glucokinase Activator

Prostaglandin E 2 Regulates Foxo Activity Via the Akt Pathway: Implications for Pancreatic Islet Beta Cell Dysfunction

CK2 activity is crucial for proper glucagon expression

Β‐cell Glucokinase Expression Was Increased in Type 2 Diabetes Subjects with Better Glycemic Control

Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes

α-cell glucokinase suppresses glucose-regulated glucagon secretion

Newer perspective on the coupling between glucose-mediated signaling and β-cell functionality.

Regulation of Hepatic Glucose Production by Transforming Growth Factor Beta 1 Via Protein Kinase A

Liver Glucokinase Can Be Activated By Peroxisome Proliferator - Activated Receptor-Gamma

Glucokinase and Diabetes Mellitus

Inhibition of PI-3 Kinase/akt/mtor, but Not Calcineurin Signaling, Reverses Insulin-Like Growth Factor I-induced Protection Against Glucose Toxicity in Cardiomyocyte Contractile Function

IGF-I Stimulates CCN5/WISP2 Gene Expression in Pancreatic Β-Cells, Which Promotes Cell Proliferation and Survival Against Streptozotocin.

TBK1 regulates regeneration of pancreatic β-cells

Effects of glucose and insulin on glucokinase activity in rat hypothalamus

Phenotypic characterization of congenital hyperinsulinism due to novel activating glucokinase mutations

Role of serum- and glucocorticoid-inducible kinase 1 in the regulation of hepatic gluconeogenesis.

Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis Through Akt-FoxO1 Interaction